Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines

• Published in: Journal of clinical immunology Vol. 27; no. 6; pp. 647 - 658
• Main Authors: Brinkman, D M C, Jol-van der Zijde, C M, ten Dam, M M, te Boekhorst, P A W, ten Cate, R, Wulffraat, N M, Hintzen, R Q, Vossen, J M, van Tol, M J D
• Format: Journal Article
• Language: English
• Published: Netherlands Springer US 01.11.2007
• Subjects: Adolescent; Adult; Autoimmune Diseases - therapy; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunity, Innate; Immunologic Memory - immunology; Male; Middle Aged; Prospective Studies; Rabies Vaccines - immunology; Tetanus Toxoid - immunology; Transplantation, Autologous; Treatment Outcome
• ISSN: 0271-9142; 1573-2592
• DOI: 10.1007/s10875-007-9120-0

Autologous stem cell transplantation (ASCT) to treat autoimmune diseases (AID) is thought to reset immunological memory directed against autoantigens. This hypothesis can only be studied indirectly because the exact nature of the pathogenetic autoantigens is unknown in most AID. Therefore, 19 children with juvenile idiopathic arthritis (JIA) or systemic lupus erythematodes (SLE) and 10 adults with multiple sclerosis (MS) were vaccinated with the T-cell-dependent neoantigen rabies and the recall antigen tetanus toxoid after, respectively before, bone marrow harvest. Both vaccinations were repeated after ASCT. All except two of the responders mounted a primary antibody response to rabies after revaccination, and 44% of the responders mounted a primary antibody response to tetanus boost after ASCT. These data show that immunological memory to a neoantigen is lost in most patients with AID after immunoablative pretreatment; however, memory to a recall antigen boosted before bone marrow harvest is only lost in part of the patients. Disease progression was arrested in all patients with JIA/SLE except one, but only in a minority of MS patients. Clinical outcome on a per case basis was not associated with the profile of the immune response toward the vaccination antigens after ASCT.